NPS Pharmaceuticals (NPSP) in Focus: Stock Rises 13.4%

Zacks

NPS Pharmaceuticals, Inc. (NPSP) was a big mover last session with its shares rising over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading way above the past one month’s volatile price range of $24.17 to $28.64.
 
This biopharmaceutical company has seen 8 negative estimate revisions in the last 30 days. The Zacks Consensus Estimate has also moved lower over the same time frame. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if Friday’s rally can last.

NPS Pharmaceuticals currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is 0.00%.

Investors interested in the Med-Drugs industry may consider better-ranked stocks like Ariad Pharmaceuticals Inc. (ARIA), Avanir Pharmaceuticals, Inc. (AVNR) and Aeolus Pharmaceuticals Inc. (AOLS). All the three stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



NPS PHARMACEUTICALS INC (NPSP): Free Stock Analysis Report

ARIAD PHARMACEUTICALS INC (ARIA): Free Stock Analysis Report

AVANIR PHARMACEUTICALS INC (AVNR): Free Stock Analysis Report

AEOLUS PHARMACEUTICL (AOLS): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)